2014

PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public OfferingMarketWatchThe Company has also granted the underwriters a 45-day option to purchase up to an additional 525,000 shares of common stock and/or 525,000 warrants to cover over-allotments, if any. H.C. Wainwright & Co. and Aegis Capital Corp. are acting as joint … and more …read more

Interleukin Genetics snags $10 mlnThomson Reuters’ peHUB (press release)Pursuant to the purchase agreement, the Company has agreed to issue an aggregate of 50,099,700 shares of the Company’s common stock at a price per share of $0.1003, as well as warrants to purchase up to an aggregate of 50,099,700 shares of common … …read more

Palatin Completes $20 Million Equity and $10 Million Debt FinancingsCNNMoneyThe Series C warrants are subject to limitation on exercise if QVT and its affiliates would beneficially own more than 9.99% (4.99% for the other accredited investment fund holder) of the total number of Palatin’s shares of common stock following such … and more …read more

Harte Gold Announces Initial Closing Under Private PlacementMarketWatchFinder’s fees payable under the private placement consist of a cash payment equal to 5% of cash raised and that number of common share purchase warrants equal to 5% of the number of Units and FT Units issued pursuant to certain orders, for a total of … and